<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>35 cases of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease are presented including 16 vascular manifestations: 14 veinous <z:mp ids='MP_0005048'>thrombosis</z:mp> with 9 vena cava obstruction; 1 femoral <z:hpo ids='HP_0002617'>aneurysm</z:hpo>; 2 pulmonar arteries <z:mp ids='MP_0005048'>thrombosis</z:mp>; 3 <z:hpo ids='HP_0001701'>pericarditis</z:hpo>; 2 <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> these cases <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> and anti-coagulation therapy were instituted </plain></SENT>
<SENT sid="2" pm="."><plain>With a follow-up from 5 to 36 months, only 5 relapsed in the five first months of therapy </plain></SENT>
<SENT sid="3" pm="."><plain>The authors suggest systematic anticoagulation or anti-agregant therapy in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease </plain></SENT>
</text></document>